Table 3.
Any regimen (all gestations)* |
Mifepristone plus misoprostol |
Misoprostol alone |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
All gestations | <7 weeks | 7 to <9 weeks | 9 to <12 weeks | 12 to 22 weeks | All gestations | <7 weeks | 7 to <9 weeks | 9 to <12 weeks | 12 to 22 weeks | ||
1 week after taking the pills† | |||||||||||
Complete without surgical intervention | 868/919 (94%) | 300/325 (92%) | 126/132 (95%) | 112/122 (92%) | 41/45 (91%) | 21/26 (81%) | 566/592 (96%) | 317/329 (96%) | 165/174 (95%) | 70/75 (93%) | 14/14 (100%) |
Complete with surgical intervention | 10/919 (1%) | 9/325 (3%) | 1/132 (1%) | 2/122 (2%) | 2/45 (4%) | 4/26 (15%) | 1/592 (<1%) | 1/329 (<1%) | 0 | 0 | 0 |
Incomplete or unsure | 40/919 (4%) | 16/325 (5%) | 5/132 (4%) | 8/122 (7%) | 2/45 (4%) | 1/26 (4%) | 24/592 (4%) | 11/329 (3%) | 9/174 (5%) | 4/75 (5%) | 0 |
Missing | 1/919 (<1%) | 0 | 0 | 0 | 0 | 0 | 1/592 (<1%) | 0 | 0 | 1/75 (1%) | 0 |
At last follow-up (up to 4 weeks after taking first dose) | |||||||||||
Complete without surgical intervention | 922/951 (97%) | 334/356 (94%) | 134/141 (95%) | 131/134 (98%) | 46/50 (92%) | 23/31 (74%) | 586/593 (99%) | 327/330 (99%) | 172/174 (99%) | 74/75 (99%) | 13/14 (93%) |
Complete with surgical intervention | 17/951 (2%) | 14/356 (4%) | 2/141 (1%) | 2/134 (1%) | 3/50 (6%) | 7/31 (23%) | 3/593 (1%) | 2/330 (1%) | 0 | 0 | 1/14 (7%) |
Incomplete or unsure | 10/951 (1%) | 8/356 (2%) | 5/141 (4%) | 1/134 (1%) | 1/50 (2%) | 1/31 (3%) | 2/593 (<1%) | 1/330 (<1%) | 1/174 (1%) | 0 | 0 |
Missing | 2/951 (<1%) | 0 | 0 | 0 | 0 | 0 | 2/593 (<1%) | 0 | 1/174 (1%) | 1/75 (1%) | 0 |
Data are n/N (%).
Includes two participants with unknown medication abortion regimen.
32 participants who did not complete a first follow-up are excluded from the denominator for the 1-week outcomes.